COMMUNIQUÉS West-GlobeNewswire

Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting
26/03/2025
LONDON and PHILADELPHIA, March 26, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads [...]
Microbix Further Optimizes Capital Usage and Availability
26/03/2025
Debt Repayment & Credit Expansion Provides Savings & Maintains Resilience MISSISSAUGA, Ontario, March 26, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences [...]
Hair Loss Hero: 2DDR HEALTHCARE Shares Results From Customer Driven Hair Loss Research Study
26/03/2025
2DDR HEALTHCARE, LLC reveals promising hair growth results with new serum, evidencing new hair growth within 6-12 weeks. Dover, Delaware, March 26, 2025 (GLOBE NEWSWIRE) -- 2DDR HEALTHCARE, LLC, a biosciences company [...]
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
26/03/2025
WEST CHESTER, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring [...]
Zymeworks Announces Participation in Upcoming Investor Conferences
26/03/2025
VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve [...]
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)
26/03/2025
REYKJAVIK, Iceland, PISCATAWAY, N.J. and LONDON, March 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for [...]
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)
26/03/2025
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical [...]
FDA Issues Nyxoah an Approvable Letter for its Genio® System
26/03/2025
INSIDE INFORMATION REGULATED INFORMATION FDA Issues Nyxoah an Approvable Letter for its Genio® System Mont-Saint-Guibert, Belgium – March 26, 2025, 8:00am CET / 3:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“ [...]
La FDA Délivre à Nyxoah une Lettre d'Approuvabilité pour son système Genio®
26/03/2025
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES La FDA Délivre à Nyxoah une Lettre d'Approuvabilité pour son Système Genio® Mont-Saint-Guibert, Belgique – 26 mars 2025, 8h00 CET / 3h00 ET – Nyxoah SA (Euronext [...]
Pleco Therapeutics Announces Positive Outcome of Pre-IND meeting with FDA for PTX-252 in Acute Myeloid Leukaemia
26/03/2025
NIJMEGEN, The Netherlands, March 26, 2025 (GLOBE NEWSWIRE) -- Pleco Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for difficult-to-treat cancers, announces a positive outcome from [...]
ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility
26/03/2025
The ARC-IM Lumbar Lead is the second model in the ARC-IM Lead family to be used in a clinical feasibility study The Company is building a portfolio of purpose-designed leads to optimize delivery of ARC-IM Therapy at [...]
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
26/03/2025
Chlamydia vaccine candidate granted fast track designation by the US FDA Chlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to pregnancy complications or infertility A phase 1/2 [...]
Communiqué de presse : La FDA des États-Unis accorde une procédure accélérée au candidat-vaccin contre les infections à Chlamydia
26/03/2025
La FDA des États-Unis accorde une procédure accélérée au candidat-vaccin contre les infections à Chlamydia Les infections à Chlamydia peuvent contribuer à l’apparition d’inflammations pelviennes chez la femme et être à [...]
BioVersys Reports Corporate Highlights and Key Financials for the Full Year 2024
26/03/2025
BASEL, Switzerland, March 26, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR BV100: Positive Phase 2 VABP trial read-out with excellent safety and efficacy data Alpibectir: Phase 2a EBA trial [...]
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
26/03/2025
DURHAM, N.C., March 25, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, [...]
Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025
26/03/2025
ROCKVILLE, Md. and SUZHOU, China, March 25, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to [...]
Biomea Fusion Announces Leadership Transition
26/03/2025
Board member Mick Hitchcock named interim CEO replacing Thomas Butler. COO and President Ramses Erdtmann continuing at Biomea in current role. REDWOOD CITY, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc [...]
Dr. Thierry Jacquemin Expands His Innovative Approach to Health, Performance, and Aesthetic Wellness
25/03/2025
Renowned physician enhances personalized wellness solutions with advanced treatments in anti-aging, performance optimization, and regenerative medicine MIAMI, March 25, 2025 (GLOBE NEWSWIRE) -- As demand for [...]
Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
25/03/2025
SAN JOSE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics [...]

Pages